Search

everythinglearnresearchcommunity

for

Search:↓

People with hair loss often have lower levels of zinc and copper in their blood.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

There is no significant link between male pattern baldness and insulin resistance.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Early hair loss may be linked to metabolic syndrome.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Minoxidil helps protect and rebuild elastic fibers in arteries, improving artery function, especially in older females.

Higher hair calcium to magnesium ratios and lower chromium levels in hair may indicate insulin resistance in Korean men.

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Higher Alarin levels may predict androgenetic alopecia and metabolic syndrome.

Obesity can worsen wound healing by negatively affecting the function of stem cells in fat tissue.

Classical PCOS types A and B are most common and linked to higher health risks.

Hair loss may indicate higher heart risk and metabolic issues.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

HIV-positive pregnant women are more likely to experience severe bleeding, and a pregnant woman with familial hypertriglyceridemia had a successful early delivery with special care.

Men with male pattern baldness have increased arterial stiffness.

Ingesting minoxidil can cause serious heart issues; keep away from children and improve packaging.

Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.